Showing results (21-30 of 47) with videos related to
Sort By:
Pageof 5
Analytical Biochemistry|August 26, 1998
Pulsed ultrafiltration characterization of bindingC J Chen, S Chen, C P Woodbury, et al.Biochimica Et Biophysica Acta|March 1, 1984
Entrapment of a highly specific antiprogesterone antiserum using polysiloxane copolymersD L Venton, K L Cheesman, R T Chatterton, et al.Fertility and Sterility|October 1, 1982
Ability of implants of polymer-entrapped antiprogesterone antiserum to absorb and deplete progesterone from serum of the pregnant ratK L Cheesman, R T Chatterton, R R Mehta, et al.The Journal of Biological Chemistry|April 5, 1992
Selective modulation of the human platelet thromboxane A2/prostaglandin H2 receptor by eicosapentaenoic and docosahexaenoic acids in intact platelets and solubilized platelet membranesC A Parent, M Lagarde, D L Venton, et al.Prostaglandins, Leukotrienes, and Essential Fatty Acids|May 1, 1988
Immobilization of catalytically active thromboxane synthaseE R Hall, G L Townsend, W M Tuan, et al.Journal of Cardiovascular Pharmacology|July 1, 1984
Antagonism of prostanoid-induced vascular contraction by 13-azaprostanoic acid (13-APA)P T Horn, J D Kohli, G C LeBreton, et al.Journal of Medicinal Chemistry|July 1, 1983
2-(6-carboxyhexyl)cyclopentanone hexylhydrazone. A potent and time-dependent inhibitor of platelet aggregationN I Ghali, D L Venton, S C Hung, et al.Prostaglandins|April 1, 1984
2-(6-carboxyhexyl)cyclopentanone hexylhydrazone: a potent inhibitor of the blood platelet cyclo-oxygenaseG C Le Breton, S C Hung, N I Ghali, et al.Prostaglandins|August 1, 1982
Prostaglandin F2 alpha antagonizes thromboxane A2-induced human platelet aggregationS C Hung, N I Ghali, D L Venton, et al.Biochimica Et Biophysica Acta|February 1, 1983
Specific binding of the thromboxane A2 antagonist 13-azaprostanoic acid to human platelet membranesS C Hung, N I Ghali, D L Venton, et al.Pageof 5